News All News

For more than three decades, Greg Verdine has brought bold, innovative methods to solving some of medicine’s biggest challenges - from early-stage work backed by the Harvard Blavatnik Biomedical Accelerator to the launch of multiple startups.

10 new technologies tackling urgent challenges from autoimmune disease to cancer win funding from Blavatnik Biomedical Accelerator.

Investigating the reasons behind the stall in the decline of cardiovascular disease deaths in the U.S. and the new scientific innovations emerging from Harvard labs that aim to improve treatment and drive death rates down.

With funding and business development support from the Blavatnik Biomedical Accelerator, a research team’s lab discovery propelled to startup success.